Medicaid spending on non-oral drug administration services in Sells jumps 41.1% for 2024

Sells Medicaid providers submitted $275,357 in claims for Drugs Administered Other than Oral Method services in 2024, using data drawn from the U.S. Department of Health and Human Services Medicaid Provider Spending database. That represents a 41.1% rise from 2023, when the total for the same service category reached $195,156.

Medicaid is a government health insurance program overseen by states and jointly funded by state and federal governments. The program provides coverage for low-income families, seniors, children, and people with disabilities, representing one of the largest components of the national health care system.

Since Medicaid payments are sourced from taxes, fluctuations in claims activity provide insight into community health care spending priorities.

The Drugs Administered Other than Oral Method service category encompasses a set of Medicaid-billed services grouped by type of treatment, sorted through standardized HCPCS and CPT billing codes. Each code in this study was assigned to one service category, using the same code ranges and prefixes—allowing related services to be tracked together, reducing counting errors, and maintaining accurate service comparisons over time.

While overall Medicaid spending has risen for various service types, Drugs Administered Other than Oral Method was third in Sells by total Medicaid payments in 2024.

On a statewide basis, this category ranked 10th by total Medicaid payments across Arizona in 2024.

From 2019 to 2024, Medicaid payments linked to Drugs Administered Other than Oral Method in Sells rose by $275,357, or 0%. The pace of spending climbed more quickly in certain periods, with notable annual increases in both 2023 and 2022.

Drugs Administered Other than Oral Method services saw Medicaid payments concentrated in only a few Sells ZIP codes. In 2024, ZIP code 85634 accounted for nearly all of this category’s Medicaid claims—totaling $275,356. Combined, the leading ZIP code represented 100% of Drugs Administered Other than Oral Method payments in Sells for the year.

Only a small number of billing codes dominated Medicaid payments for Drugs Administered Other than Oral Method service claims.

To compare, Medicaid payments for this service group in Sells increased by 41.1% from 2023 to 2024, while Medicaid payments across all claim categories in the city grew by 35.8% over the same time period.

According to the Centers for Medicare & Medicaid Services, federal and state Medicaid spending combined totaled close to $871.7 billion in fiscal year 2023, which made up roughly 18% of national health expenditures. That was a marked increase from $613.5 billion in 2019 ahead of the COVID-19 pandemic.

This rise signifies a nearly 40% growth in just a few years, primarily fueled by higher enrollment and use of health services during and after the pandemic.

Recent federal budget actions under the Trump administration have put forward substantial proposals to decrease federal spending on Medicaid and overhaul the program’s structure. One example is the “One Big Beautiful Bill Act,” passed in 2025, which is expected to reduce federal Medicaid spending by more than $1 trillion over the upcoming decade. This law introduces measures such as work requirements and higher cost-sharing that could reduce access and funding for certain enrollees. These changes are anticipated to shift increased financial responsibility onto states and curb the expansion of federal Medicaid funding, even as tens of millions of Americans continue to be served.

Note: HCPCS codes are shown for context within the category. Category totals and rankings in this article are based on standardized service groupings rather than individual billing codes.

Information in this article was obtained from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The source data can be found here.